Donoghue Forlines’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,743
Closed -$2.95M 131
2025
Q2
$2.95M Buy
+16,743
New +$2.52M 0.84% 16
2024
Q4
Sell
-9,064
Closed -$1.51M 260
2024
Q3
$1.51M Sell
9,064
-2,126
-19% -$322K 0.43% 61
2024
Q2
$1.49M Sell
11,190
-5,811
-34% -$700K 0.42% 57
2024
Q1
$1.79M Sell
17,001
-2,325
-12% -$209K 0.51% 44
2023
Q4
$1.46M Buy
+19,326
New +$1.23M 0.46% 54

Other funds holding THC

Donoghue Forlines's THC Position: Q3 2025 in Review

Donoghue Forlines sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 16,743 shares — an estimated $2.95M sold.

Donoghue Forlines first reported a position in THC in Q4 2023 and held it in 5 quarters. The position peaked at $2.95M in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Donoghue Forlines reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Donoghue Forlines sold 16,743 Tenet Healthcare shares in Q3 2025, an estimated $2.95M.
  • Donoghue Forlines first reported a position in Tenet Healthcare in Q4 2023 and held it in 5 quarters.
  • Donoghue Forlines's Tenet Healthcare position peaked at $2.95M in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Donoghue Forlines's 13F filing for Q3 2025, filed 29 Oct 2025.